Actividades asistenciales
COMPOSITION IN POWDER FORM COMPRISING IRON-CASEIN COMPLEXES AND COMPOUNDS SENSITIVE TO OXIDATION
30/10/2023 -
The present invention relates to a composition comprising compounds sensitive to oxidation and at least one iron-casein protein complex, wherein the complex is a non-micellar iron-casein complex...
A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID
28/12/2023 -
This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), [Formula I] and crystalline solid forms and compositions thereof. Also disclosed herein are methods of...
SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE
31/10/2023 -
The present application relates to novel (imidazo[1,2-a]pyridin-3-yl)methyl-substituted diazaheterobicyclic compounds, to processes for preparation thereof, to the use thereof alone or in...
BENZODIAZEPINE DERIVATIVE WITH ACTIVITY ON THE CENTRAL NERVOUS AND VASCULAR SYSTEMS
24/10/2023 -
Formula III compound, its products and pharmaceutical compositions containing them for the treatment of central nervous and vascular system diseases, particularly neurodegenerative disorders with...
Anticuerpo anti-trem2 y usos del mismo
29/08/2025 -
La presente invención proporciona anticuerpos anti-TREM2, formulaciones de los mismos, y métodos de uso de los mismos.
COMPOSITION FOR IMPROVING BRAIN FUNCTION FOR NEONATES
19/12/2023 -
An object of the present invention is to provide a brain function improving agent for neonates, especially, newborn neonates. According to the present invention, there is provided a brain function...
PARENTERAL LIQUID PREPARATION COMPRISING CARBAMATE COMPOUND
09/12/2023 -
The present invention relates to a parenteral liquid preparation containing, as active ingredients; a carbamate compound of chemical formula 1, an isomer thereof, or a phannaceutically acceptable...
ANTI-TAU ANTIBODIES AND METHODS OF USE
03/10/2023 -
The application provides antitau antibodies and methods for their use. Claim 1: An isolated antibody that binds to human tau, wherein the antibody comprises HVR-H1 comprising the amino acid...
METHODS OF TREATING INFLAMMATORY CONDITIONS
26/12/2023 -
The present invention provides methods for treating inflammatory diseases, or conditions associated with, or resulting in part from, elevated levels of IL-33 and IL-4, in particular inflammatory...
血液脳関門を通過させるための組成物及び方法
26/08/2025 -
...
HUMAN ANTIBODIES TO S. AUREUS HEMOLYSIN A TOXIN
01/12/2023 -
The present invention provides antibodies that bind to Staphylococcus aureus Hemolysin A toxin, and methods of use. According to certain embodiments of the invention, the antibodies are fully...
ナフチルアミン構造を有する低分子化合物の使用
26/08/2025 -
...
ミエロペルオキシダーゼの阻害剤
26/08/2025 -
...
抗配列類似性19を持つファミリー、メンバーA5抗体及びその使用方法
26/08/2025 -
...
神経障害の治療に使用するための化合物
26/08/2025 -
...
中枢神経系への細胞特異的輸送のための二重標的化
26/08/2025 -
...
KLK5阻害剤及びその製造方法
26/08/2025 -
...
KINASE INHIBITORS AND USES THEREOF
20/12/2023 -
The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors. No Figure
遺伝性血管性浮腫の治療
26/08/2025 -
...
METHOD AND TOOL FOR PREDICTING LANGUAGE DEVELOPMENT AND COMMUNICATION CAPABILITIES OF INFANT AND TODDLER
28/08/2025 -
A method for predicting a development level difference of language and communication capability normality of a healthy infant or toddler. The method comprises obtaining electroencephalogram (EEG)...
腰の筋力を補助する着用型ロボット、又は着用型ロボットの操作装置
26/08/2025 -
...